Skip to main content
PeptideClinicLocator logoPeptideClinicLocator
The Journal

Peptide Therapy Insights

Evidence-based guides, regulatory updates, and expert perspectives on peptide therapy. Stay informed with the latest research and clinical insights.

More in Regulatory

Is GHRH Legal? FDA Status and Regulations Explained (2026)
Regulatory

Is GHRH Legal? FDA Status and Regulations Explained (2026)

Explore the legal status of GHRH, including FDA regulations, compounding legality, and what patients need to know.

Read article
Is Gonadorelin Legal? FDA Status and Regulations Explained (2026)
Regulatory

Is Gonadorelin Legal? FDA Status and Regulations Explained (2026)

Explore the legal status of Gonadorelin, its FDA classification, compounding legality, and what patients need to know about its use in 2026.

Read article
Is Melanotan 2 (MT2) Legal? FDA Status and Regulations Explained (2026)
Regulatory

Is Melanotan 2 (MT2) Legal? FDA Status and Regulations Explained (2026)

Explore the legal status of Melanotan 2 (MT2), including FDA regulations, compounding legality, and enforcement actions.

Read article
Is Matrixyl Legal? FDA Status and Regulations Explained (2026)
Regulatory

Is Matrixyl Legal? FDA Status and Regulations Explained (2026)

Explore the legal status of Matrixyl, its FDA classification, and what this means for patients and practitioners in 2026.

Read article
Is O-304 Legal? FDA Status and Regulations Explained (2026)
Regulatory

Is O-304 Legal? FDA Status and Regulations Explained (2026)

Explore the legal status of O-304, its FDA classification, compounding regulations, and what patients need to know about this research compound.

Read article
Is Ovagen Legal? FDA Status and Regulations Explained (2026)
Regulatory

Is Ovagen Legal? FDA Status and Regulations Explained (2026)

Explore the legal status of Ovagen, a peptide bioregulator, including its FDA and compounding status, enforcement actions, and implications for patients.

Read article
Is Pal-AHK Legal? FDA Status and Regulations Explained (2026)
Regulatory

Is Pal-AHK Legal? FDA Status and Regulations Explained (2026)

Explore the legal status of Pal-AHK, a research peptide known for tissue regeneration. Understand its FDA classification, compounding legality, and implications for patients.

Read article
Is Pal-GHK (Palmitoyl Tripeptide-1) Legal? FDA Status and Regulations Explained (2026)
Regulatory

Is Pal-GHK (Palmitoyl Tripeptide-1) Legal? FDA Status and Regulations Explained (2026)

Explore the legal status of Pal-GHK (Palmitoyl Tripeptide-1), its FDA status, compounding legality, and what patients need to know about this research peptide.

Read article
Is Palmitoyl Dipeptide-6 Legal? FDA Status and Regulations Explained (2026)
Regulatory

Is Palmitoyl Dipeptide-6 Legal? FDA Status and Regulations Explained (2026)

Explore the legal status of Palmitoyl Dipeptide-6, including its FDA status, compounding regulations, and implications for patients.

Read article

Stay Up to Date

New articles on peptide therapy, FDA regulations, and clinic reviews are published regularly. Bookmark this page or check back often.